153 related articles for article (PubMed ID: 7899248)
21. A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.
Wang J; Xia S; Xue W; Wang D; Sai Y; Liu L; Liu X
Eur J Pharm Sci; 2013 Nov; 50(3-4):290-302. PubMed ID: 23916407
[TBL] [Abstract][Full Text] [Related]
22. Chiral capillary electrophoretic analysis of verapamil metabolism by cytochrome P450 3A4.
Ha PT; Sluyts I; Van Dyck S; Zhang J; Gilissen RA; Hoogmartens J; VanSchepdael A
J Chromatogr A; 2006 Jul; 1120(1-2):94-101. PubMed ID: 16376901
[TBL] [Abstract][Full Text] [Related]
23. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects.
Murthy SS; Nelson WL; Shen DD; Power JM; Cahill CM; McLean AJ
Drug Metab Dispos; 1991; 19(6):1093-100. PubMed ID: 1687016
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney.
Higaki K; Kadono K; Goto S; Nakano M
J Pharmacol Exp Ther; 1994 Jul; 270(1):329-35. PubMed ID: 8035328
[TBL] [Abstract][Full Text] [Related]
26. Enantioselective disposition and protein binding of [(5,6-dichloro-9a-propyl-3-oxo-2,3,9,9a-tetrahydro-1-H-fluoren-7 -yl)-oxy] acetic acid, a new cerebral antiedemic agent, in rats.
Lin JH; Hsieh JY
Drug Metab Dispos; 1988; 16(4):540-5. PubMed ID: 2903020
[TBL] [Abstract][Full Text] [Related]
27. (S)-4'-hydroxypropranolol causes product inhibition and dose-dependent bioavailability of propranolol enantiomers in the isolated perfused rat liver and in rat liver microsomes.
Nand RA; Ghabrial H; Smallwood RA; Morgan DJ
Xenobiotica; 1996 Dec; 26(12):1249-61. PubMed ID: 9004455
[TBL] [Abstract][Full Text] [Related]
28. Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines.
Häussermann K; Benz B; Gekeler V; Schumacher K; Eichelbaum M
Eur J Clin Pharmacol; 1991; 40(1):53-9. PubMed ID: 2060546
[TBL] [Abstract][Full Text] [Related]
29. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
Johnson LM; Lankford SM; Bai SA
J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
[TBL] [Abstract][Full Text] [Related]
30. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice.
Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS
Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817
[TBL] [Abstract][Full Text] [Related]
31. Enantioselective transport and CYP3A4-mediated metabolism of R/S-verapamil in Caco-2 cell monolayers.
Engman H; Tannergren C; Artursson P; Lennernäs H
Eur J Pharm Sci; 2003 May; 19(1):57-65. PubMed ID: 12729862
[TBL] [Abstract][Full Text] [Related]
32. Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites.
Wang YH; Jones DR; Hall SD
Drug Metab Dispos; 2004 Feb; 32(2):259-66. PubMed ID: 14744949
[TBL] [Abstract][Full Text] [Related]
33. Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding.
Hanada K; Akimoto S; Mitsui K; Mihara K; Ogata H
Pharm Res; 1998 Aug; 15(8):1250-6. PubMed ID: 9706057
[TBL] [Abstract][Full Text] [Related]
34. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
[TBL] [Abstract][Full Text] [Related]
35. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
[TBL] [Abstract][Full Text] [Related]
36. Effect of Huang-Lian-Jie-Du-Decoction on pharmacokinetics of verapamil in rats.
Xie SS; Hu N; Jing XY; Liu XD; Xie L; Wang GJ; Liu CH
J Pharm Pharmacol; 2010 Apr; 62(4):440-7. PubMed ID: 20604832
[TBL] [Abstract][Full Text] [Related]
37. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
Polhuijs M; Gasinska I; Cherry WF; Mulder GJ; Pang KS
J Pharmacol Exp Ther; 1993 Jun; 265(3):1406-12. PubMed ID: 8510017
[TBL] [Abstract][Full Text] [Related]
38. Stereoselective CZE method for analysis of verapamil and norverapamil in human plasma.
Resztak M; Główka FK
Acta Pol Pharm; 2013; 70(3):395-401. PubMed ID: 23757929
[TBL] [Abstract][Full Text] [Related]
39. Influence of albumin on enantioselective local disposition of BOF-4272, a xanthine oxidase inhibitor with chiral sulfoxide, in rat liver.
Nishimura M; Yamaoka K; Naito S; Nakagawa T
Biol Pharm Bull; 1997 Dec; 20(12):1285-9. PubMed ID: 9448105
[TBL] [Abstract][Full Text] [Related]
40. Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: implication of concentrative uptake of inhibitors into liver.
Yamano K; Yamamoto K; Kotaki H; Takedomi S; Matsuo H; Sawada Y; Iga T
J Pharmacol Exp Ther; 2000 Mar; 292(3):1118-26. PubMed ID: 10688631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
